Alcon to acquire ESBATech

Alcon Inc. (NYSE:ACL) will acquire ESBATech AG (Zurich, Switzerland) for $150 million in cash and up to $439 million in milestones. The acquisition includes ophthalmic applications of ESBATech's compo...